Literature DB >> 30381071

Erythropoietin Directly Affects Human Macrophage Functionality.

Olga V Melashchenko1, Maxim E Meniailo1, Vladimir V Malashchenko1, Natalya D Gazatova1, Andrei G Goncharov1, Galina V Seledtsova2, Victor I Seledtsov1.   

Abstract

OBJECTIVE: We studied direct effects of Erythropoietin (Epo) on functional properties of human monocytes/macrophages (Mc/Mphs) in vitro.
METHODS: Cells expressing CD14 marker were isolated from human peripheral blood mononuclear cells (PBMCs) by positive magnetic separation. Mc/Mphs were cultured without or with bacterial lipopolysaccharide (LPS) in the absence or presence of Epo for 24 h.
RESULTS: We showed that Epo treatment hoticeably reduces the percentages of CD14+ cells, CD124 (alpha subunit of IL-4 receptor)+ cells and CD197 (CCR7)+ cells in non-activated Mph cultures without affecting the levels of CD16 (low-affinity Fc-receptor)+ and CD119 (interferon-γ (IFN-γ) receptor)+ cells. Epo also markedly reduced percentages of CD197+ cells in LPS-activated Mc/Mphs, without significantly affecting the expression of all other molecular markers studied. In addition, Epo caused moderate up-regulation of interleukin-1β (IL-1β) and IL-6 production in resting Mc/Mph cultures, as compared to the down-regulation of IL-1β and IL-6 production in LPS-activated cells. No Epomediated effects on tumor necrosis factor-α (TNF-α) and IL-10 production were observed.
CONCLUSION: Our data suggests that Epo effects on Mph functionality are largely dependent on the baseline activation status of these cells, and that Epo exerts no distinct direct effects on the particular Mph polarization pathway. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Erythropoietin; PBMCs; cytokine; immunoregulation; lipopolysaccharide; monocyte/macrophage.

Mesh:

Substances:

Year:  2018        PMID: 30381071     DOI: 10.2174/1389201019666181031164520

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  4 in total

1.  Directs effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on adaptive immunogenesis.

Authors:  Victor Ivanovich Seledtsov; Vladimir V Malashchenko; Natalja D Gazatova; Maksim E Meniailo; Ekaterina M Morozova; Galina V Seledtsova
Journal:  Hum Vaccin Immunother       Date:  2019-05-22       Impact factor: 3.452

2.  Effect of Erythropoietin on Mononuclear Cells of the Bone Marrow and Spleen.

Authors:  A P Lykov; M A Surovtseva; N A Bondarenko; I I Kim; Ya Sh Schwartz; O V Poveshchenko
Journal:  Bull Exp Biol Med       Date:  2022-10-10       Impact factor: 0.737

3.  Evaluation of topical erythropoietin application on the healing outcome of gingival graft recipient site; a randomized controlled clinical trial.

Authors:  Siamak Yaghobee; Nina Rouzmeh; Mina Taheri; Hoori Aslroosta; Sanaz Mahmoodi; Masoomeh Mohammadnejad Hardoroodi; Pardis Soleimanzadeh Azar; Afshin Khorsand
Journal:  BMC Oral Health       Date:  2021-11-12       Impact factor: 2.757

4.  A therapeutic vascular conduit to support in vivo cell-secreted therapy.

Authors:  Edward X Han; Hong Qian; Bo Jiang; Maria Figetakis; Natalia Kosyakova; George Tellides; Laura E Niklason; William G Chang
Journal:  NPJ Regen Med       Date:  2021-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.